P127 The SLE-DAS enables easy identification of SLE patients with moderate-to-severe disease activity and worse HR-QoL in the screening for SLE clinical trials: a post-hoc study in the phase 2 and 3 anifrolumab trials
| Autor: | Andrea Doria, Diogo Jesus, Ana Matos, Carla Henriques, Luís Sousa Inês |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024) |
| Druh dokumentu: | article |
| ISSN: | 2053-8790 |
| DOI: | 10.1136/lupus-2024-el.181 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|